Last updated: October 27, 2020
Sponsor: The University of Hong Kong
Overall Status: Completed
Phase
3
Condition
Uterina Myoma
Desmoid Tumors
Uterine Fibroids
Treatment
N/AClinical Study ID
NCT02189083
HKU-SCM-TSD2014
HMRF-11121841
Ages 18-52 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Premenopausal women aged 18 to 52 years; and
- have a primary diagnosis of symptomatic UFs based on clinical symptoms; and
- MRI examination as defined in the International Classification of Diseases (10thedition).
Exclusion
Exclusion Criteria:
- Unstable medical conditions such as serious cardiovascular diseases;
- With severe neuropsychiatric disorders;
- Combined with adenomyosis or other tumors;
- On treatment with Chinese medicine or other natural products in the previous 3 months;
- With an allergic history of herbal medicine; or
- Being pregnant and lactating women and those who currently use contraception.
Study Design
Total Participants: 78
Study Start date:
May 01, 2014
Estimated Completion Date:
February 29, 2016
Study Description
Connect with a study center
School of Chinese Medicine, University of Hong Kong
Hong Kong, 852
ChinaSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.